Evidence map›Paper›PMID 41088795›Full record

ArticleMacromolecular rapid communications2026

Hydrophilic Poly(Iminopyridinium Ylide)s: Defining a New Chemical Space for Poly(ylide)s.

Noël René Schneider, Aleksandra M Orlova, Nuwanthika Dilrukshi Kumarage, Patrick Théato, Kevin Neumann

Abstract read
In one paragraph

Article in Macromolecular rapid communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Noël René SchneiderInstitute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands.ORCID https://orcid.org/0009-0002-4265-3766
Aleksandra M OrlovaSoft Matter Synthesis Laboratory - Institute for Biological Interfaces III (IGB-3), Karlsruhe Institute of Technology, Karlsruhe, Germany.ORCID https://orcid.org/0000-0002-3378-4142
Nuwanthika Dilrukshi KumarageInstitute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-9760-5174
Patrick ThéatoSoft Matter Synthesis Laboratory - Institute for Biological Interfaces III (IGB-3), Karlsruhe Institute of Technology, Karlsruhe, Germany.ORCID https://orcid.org/0000-0002-4562-9254
Kevin NeumannInstitute for Molecules and Materials, Radboud University, Nijmegen, The Netherlands.ORCID https://orcid.org/0000-0002-6683-0774

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rising hypersensitivity to PEG and accelerated blood clearance highlight the need for alternative charge-neutral hydrophilic polymers. Poly(ylide)s represent a class of hydrophilic polymers with biocompatibility and antifouling properties. Here, we explore poly(iminopyridinium ylide) (PIPY) as a versatile nano- and biomedical building block. PIPY is synthesized via post-polymerization modification of poly(pentafluorophenyl acrylate), maintaining a narrow molecular weight distribution. PIPY's structure was confirmed by NMR, FTIR, and SEC. PIPY is soluble in water, saline, MeOH, and DMSO, and remains stable from strongly acidic to physiological pH. Critical aggregation concentration and DOSY NMR measurements indicate an anti-polyelectrolyte effect and minimal responsiveness to apolar environments, respectively. Notably, PIPY exhibits minimal, entropically driven binding to biomolecules such as bovine serum albumin and lysozyme. This low interaction is critical for its ability to prevent insulin fibrillation upon heating, suggesting utility as a protein-stabilizing matrix. These combined properties position PIPY as a promising material for future bio- and nanomedical applications.

Indexed as

PolymersAnimalsCattleHydrophobic and Hydrophilic InteractionsMolecular StructureMuramidaseSerum Albumin, BovineMuramidasePolymersSerum Albumin, Bovinebiomoleculesnanomedicinepoly(iminopyridinium ylide)spoly(ylide)post‐polymerization modificationzwitterionic polymers

Identifiers

PMID41088795
PMCPMC12784188

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.